不安定性のない不完全な子宮頸部 SCI
IN-TWIN: 不安定性のない外傷性不完全四肢麻痺: 結果と予後に関する前向き多施設実現可能性研究
A multicenter, international, prospective, observational case series patient cohort with incomplete cervical SCI without instability will be enrolled to obtain information and data that could inform the feasibility of administering a set of additional core and optional outcome assessments in cervical SCI patients to capture the aspects of neurologic impairment. Baseline, intraoperative, and postoperative characteristics, including demographics, injury details, treatment details, neurological assessments, gait and balance assessments and upper extremity assessments, will be recorded for adult patients.
調査の概要
状態
状態
条件
条件
介入・治療
介入・治療
詳細な説明
This prospective multicenter study will enroll 50 adult patients with acute traumatic cervical SCI with ISNCSCI AIS Grade D or sensory deficits only without biomechanical instability.
Patients will be assessed at the baseline visit and subsequently be followed up at 3 and 6 months. All decisions regarding the treatment and clinical management will be left to the attending spinal surgeon and will follow the local standard of care.
The core outcome assessments include:
- Neurological status by the ISNCSCI
- Patient-reported outcome measures (PROMs) of Short Form-36 (SF-36) v2 and Neuropathic Pain Scale (NPS)
- The Spinal Cord Independence Measure (SCIM) v3
- Gait and balance evaluated using the ten-meter walk test (10mWT) and Walking Index for Spinal Cord Injury (WISCI) v2
- Upper extremity impairment evaluated using the grip strength with digital dynamometry, pinch strength (key pinch and tip-to-tip pinch), and the Partial Graded Redefined Assessment of Strength Sensibility and Prehension (GRASSP) v2.
All core outcome assessments will be performed at the baseline, 3-, and 6-month visits except for the PROMs, SCIM v3, key pinch and tip-to-tip pinch, which will be assessed only at the 3- and 6-month visits.
The optional outcome assessment is the multiparametric quantitative spinal cord magnetic resonance imaging (MRI)/diffusion tensor imaging (DTI) which will be performed at baseline, 3-, and 6-month visits if it is done at the surgeon's discretion.
The goal of this study is to obtain information and data that could inform the feasibility of administering a set of additional core and optional outcome assessments in cervical SCI patients with incomplete tetraplegia without spinal instability to capture the aspects of neurologic impairment that may not be well represented in the ISNCSCI examination.
研究の種類
研究の種類
入学 (実際)
入学
連絡先と場所
研究場所
-
-
California
-
San Francisco、California、アメリカ、94143
- San Francisco General Hospital
-
-
Maryland
-
Baltimore、Maryland、アメリカ、21201
- UMD STC Neurosurgery Clinic
-
-
Wisconsin
-
Milwaukee、Wisconsin、アメリカ、53226
- Medical college of Winsconsine, Neurosurgery
-
-
-
-
-
New Delhi、インド、110070
- Indian Spinal Injuries Centre
-
-
-
-
-
Toronto、カナダ、M5B1W8
- St. Michael's Hospital
-
Toronto、カナダ、M6S2W5
- Toronto Western Hospital University Health Network
-
Vancouver、カナダ、V5Z 1M9
- Vancouver Spine Research Program, Blusson Spinal Cord Centre
-
-
-
-
-
Murnau am Staffelsee、ドイツ、82418
- BG Klinikum Murnau gGmb, BGU Murnau, Trauma Center Murnau
-
-
-
-
-
São Paulo、ブラジル、05403-010
- Instituto de Ortopedia E Traumatologia Do Hospital Das Clinicas Da Universidade de Sao Paulo
-
-
-
-
-
Porto、ポルトガル、4099-001
- Orthopaedics, Centro Hospitalar Universitário do Porto
-
-
参加基準
適格基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
サンプリング方法
調査対象母集団
Patients with traumatic incomplete cervical SCI without instability
説明
Inclusion Criteria:
- Age 18-80 years, inclusive
- Diagnosis of acute traumatic cervical SCI with ISNCSCI AIS Grade D or sensory deficits only within 92 hours post injury
- Cervical neurological level of injury (C2-C8)
- MRI, using any imaging protocols (conventional, multiparametric, or quantitative), taken according to standard of care
- Presence of spinal cord compression on the MRI
- Absence of biomechanical instability to the extent that would mandate stabilization surgery by the treating surgeon
- Ability to provide informed consent according to the IRB/EC defined and approved procedures
Exclusion Criteria:
- Nontraumatic SCI
- Concomitant traumatic brain injury or polytrauma that could preclude accurate or reliable assessments of the outcome assessments
- Uncontrolled severe systemic diseases, preexisting neurological, musculoskeletal, or general medical conditions which could preclude accurate assessments or FUs
- Individuals unable to undergo MRI
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 観測モデル:COHORT
- 時間の展望:PROSPECTIVE
この研究は何を測定していますか?
主要な結果の測定
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
The proportion of the core outcome assessments successfully completed at each visit
時間枠:up to 6 months
|
For baseline and each FU visit, the completion status of each core outcome assessment |
up to 6 months
|
|
Time required to complete the individual core outcome assessments
時間枠:up to 6 months
|
For baseline and each FU visit, the time required for completion for each core outcome assessment will be recorded (start time, end time, and duration in mins) |
up to 6 months
|
|
Total time required to complete all core outcome assessments at each visit
時間枠:up to 6 months
|
The time required for completion will be measured to the nearest 0.1 second by using a digital timer, and the timing should start at the start of giving instructions to the patients or explaining the tests to the patients (start time) and end when the final score of the test is obtained (end time). |
up to 6 months
|
|
Completion rate of individual core outcome assessments (and their scorings if applicable)
時間枠:up to 6 months
|
Completion rate of individual core outcome assessments at each visit. |
up to 6 months
|
|
Completion rate of the multiparametric quantitative spinal cord MRI/DTI
時間枠:up to 6 months
|
Completion rate of the multiparametric quantitative spinal cord MRI/DTI |
up to 6 months
|
|
FU visit compliance rate and reasons for non-compliance
時間枠:up to 6 months
|
Completion status of FU visits, recorded at 3- and 6-month visits |
up to 6 months
|
|
Patient accrual rate
時間枠:up to 6 months
|
Whether the patient drops out from the study, recorded at the time of dropout |
up to 6 months
|
二次結果の測定
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Results from the core outcome assessment ISNCSCI
時間枠:up to 6 months
|
Motor and sensory scores (motor score 0-100, pin prick score 0-112), AIS Grades, Clinical syndrome (Central Cord/Brown-Sequard/Anterior Cord/Conus Medullaris/Cauda Equina/No clinical syndrome/Not assessed) |
up to 6 months
|
|
Results from the core outcome assessment SF-36 v2
時間枠:up to 6 months
|
Eight scale scores (0-100): physical functioning, bodily pain, role limitations due to physical health problems, role limitations due to personal or emotional problems, general mental health, social functioning, energy/fatigue or vitality, and general health perceptions |
up to 6 months
|
|
Results from the core outcome assessment Neuropathic pain score
時間枠:up to 6 months
|
Score 0-100 |
up to 6 months
|
|
Results from the core outcome assessment SCIMv3
時間枠:up to 6 months
|
Three subscales: Self-care (0-20), Respiration and Sphincter Management (0-40), Mobility (room and toilet, 0-40) |
up to 6 months
|
|
Results from the core outcome assessment WISCI v2
時間枠:up to 6 months
|
Level of walking (score 0-20) |
up to 6 months
|
|
Results from the core outcome assessment Key pinch and tip-to-tip pinch
時間枠:up to 6 months
|
Pinch strength in kg |
up to 6 months
|
|
Results from the core outcome assessment GRASSP v2
時間枠:up to 6 months
|
Eight subtest scores Strength (0-50), Palmar sensation (0-12), Prehension Ability (0-12), Prehension Performance (0-20) |
up to 6 months
|
協力者と研究者
捜査官
捜査官
- 主任研究者:Jefferson Wilson、Unity Health Toronto
研究記録日
主要日程の研究
研究開始 (実際)
研究開始
一次修了 (実際)
一次修了
研究の完了 (実際)
研究の完了
試験登録日
最初に提出
最初に提出
QC基準を満たした最初の提出物
QC基準を満たした最初の提出物
最初の投稿 (実際)
最初の投稿
学習記録の更新
投稿された最後の更新 (実際)
投稿された最後の更新
QC基準を満たした最後の更新が送信されました
QC基準を満たした最後の更新が送信されました
最終確認日
最終確認日
詳しくは
本研究に関する用語
追加の関連 MeSH 用語
その他の研究ID番号
その他の研究ID番号
- IN-TWIN
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。